HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Pulmonary Vascular DisorderPulmonary Artery HypertensionChronic Thromboembolic Pulmonary Hypertension

Interventions

OTHER

Supplemental oxygen therapy

Mobile oxygen via pressurized bottle or mobile oxygen concentrator will be applied

OTHER

Sham Oxygen therapy

Patients will reveice pressurized air via a nasal cannula

Trial Locations (1)

University Hospital Zürich, Zurich

All Listed Sponsors

lead

University of Zurich

OTHER